NumFin

Agenus Inc.

Simbol: AGEN

NASDAQ

13.07

USD

Tržna cena danes

  • -20.6369

    Razmerje P/E

  • -0.6948

    Razmerje PEG

  • 265.12M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Agenus Inc. (AGEN) Finančni izkazi

Download
LetniČetrtletno
LinearnoLog
Na grafu so prikazane privzete številke v dinamiki za Agenus Inc. (AGEN). Prihodki podjetja prikazujejo povprečje 38.956 M, ki je 1.212 % gowth. Povprečni bruto dobiček za celotno obdobje je -7.675 M, ki je 0.410 %. Povprečno razmerje bruto dobička je -0.005 %. Rast čistega dobička za lanskoletno poslovanje podjetja je -0.095 %, kar je enako -0.270 % % v povprečju v celotni zgodovini podjetja.,

LetniČetrtletno
10Y20Y30Y40Y

Bilanca stanja

Če pogledamo fiskalno pot podjetja Agenus Inc., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini -0.241. Na področju kratkoročnih sredstev AGEN znaša 112.416 v valuti poročanja. Velik del teh sredstev, natančneje 76.11, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za -0.606%. Dolgoročne naložbe podjetja, ki sicer niso v središču njegovega zanimanja, znašajo 3.669, če obstajajo, v valuti poročanja. To pomeni razliko v višini 37.467% glede na zadnje obdobje poročanja, kar odraža strateške premike družbe. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 137.324 v valuti poročanja. Ta številka pomeni medletno spremembo v višini 3.466%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo -160.331 v valuti poročanja. Letna sprememba tega vidika je 1.616%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 25.836, zaloge na 0, dobro ime pa na 24.72, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 4.41. Obveznosti in kratkoročni dolgovi so 21.37 oziroma {{short_term_deby}}. Celotni dolg je 350.25, neto dolg pa je 274.14. Druge kratkoročne obveznosti znašajo 48.74 in se dodajo k skupnim obveznostim 462.3. Nazadnje se navedena zaloga vrednoti po vrednosti {{preffered_stock}}, če obstaja.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

balance-sheet.row.cash-and-short-term-investments

529.576.1193.4306.9
99.9
61.8
53.1
60.2
76.4
171.7
40.2
27.4
21.5
10.7
19.8
30.1
34.5
18.7
40.1
61.7
86.9
89.5
58.7
60.9
99.1
46.4

balance-sheet.row.short-term-investments

39.06014.715
0
0
0
0
5
35
14.5
0
0
0
0
10
10
4.2
15.9
28.5
70.9
32.3
25.6
0
3
0

balance-sheet.row.net-receivables

29.6225.82.71.5
1.2
16.3
0.9
1.1
11.4
9.8
1.2
0
0.6
0.5
0
0.8
0.6
0.3
0.2
0
0.1
0.6
1.1
0.5
0.5
0

balance-sheet.row.inventory

35.73013.820.4
10.7
7.4
0.1
0.1
0.1
0.1
0.1
0.7
0
0
0
0.3
0.2
0.5
0.4
0.3
0.2
0.9
1
1.4
0.7
0

balance-sheet.row.other-current-assets

19.5410.53.23.2
2
1
1.5
1.1
0.8
0.6
1.1
0.2
0
0.7
0.3
0.4
0.2
0.4
0.3
0.3
0.6
0.5
0.9
0.6
1.3
1.3

balance-sheet.row.total-current-assets

614.39112.4213.1332
113.8
86.5
74.8
73.6
91.3
184.1
42.7
28.2
22.6
12
20.9
31.5
35.5
20.8
42.3
67
92.6
93.3
63.4
64
101.6
47.7

balance-sheet.row.property-plant-equipment-net

678.07163164.391.1
60.3
33.7
25.1
26.2
25.6
15.3
6
5.6
5.2
4.1
6.2
8.9
11.5
14.6
18.6
23.4
25
25
11.4
13.9
14.6
8

balance-sheet.row.goodwill

99.7424.725.524.9
25.5
23.2
22.9
23
22.4
22.8
17.9
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2572.2
2572.2
3081.7
3081.7
0
0
0

balance-sheet.row.intangible-assets

19.554.46.28.5
10.9
10.5
12.3
31.8
16.4
18.8
6.8
0
0
0
0
1.6
3.3
3.5
4.6
2.6
9.4
11
3.1
2.8
3
0

balance-sheet.row.goodwill-and-intangible-assets

119.2929.131.733.4
36.3
33.7
35.3
54.8
38.8
41.6
24.6
2.6
2.6
2.6
2.6
4.2
5.8
6.1
7.2
2.6
9.4
11
3.1
2.8
3
0

balance-sheet.row.long-term-investments

12.683.72.72.7
2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

-9.010-2.7-2.7
-2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

30.415.74.59.5
4.1
1.4
1.2
1.2
1.3
1.3
1.2
1.3
1.3
1.1
1.3
1.3
4.1
3
4.8
11.2
6
10.7
11.2
12.9
8.8
0.3

balance-sheet.row.total-non-current-assets

831.44201.5200.4134
100.7
68.8
61.6
82.2
65.7
58.1
31.9
9.4
9.1
7.8
10.1
14.3
21.5
23.8
30.7
37.2
40.5
46.8
25.7
29.6
26.4
8.3

balance-sheet.row.other-assets

0000
0
0
0
-17.4
0
0
0
-2.8
3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

1445.83313.9413.6466
214.5
155.3
136.4
138.4
157
242.2
74.5
34.8
34.7
19.8
30.9
45.9
56.9
44.5
73
104.2
133.1
140.1
89.1
93.5
128
56

balance-sheet.row.account-payables

201.5661.440.930.5
17
13.6
13.6
8.1
5.4
4.5
1.7
0.8
0.6
0.8
0.7
0.9
0.5
0.7
1.1
2.6
2.9
3.2
1.4
2.9
2.3
0.4

balance-sheet.row.short-term-debt

183.52145.72.53.4
2.8
2
0.1
20.6
0.1
0.1
1.3
3.5
0.2
0.2
0.1
0.1
0.1
0.1
0.1
4.1
5.4
5.6
0.5
5.9
2.3
0.8

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

363.62137.375.954.9
52.9
21.4
13.2
142.4
130.5
114.3
4.8
5.3
35.7
32.7
34.1
49.5
67.8
77.4
75.3
0
4.5
10.2
0
0.2
2.6
2.2

Deferred Revenue Non Current

4.571.11.111.2
28.3
27.7
1.2
7.7
12.3
15.1
3
3.2
4.8
2.1
3.6
3
3436.8
3038.3
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

67.23---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

441.4248.7133.2110.7
92.9
77.5
52.5
23.2
32.7
20.5
6.1
4.3
2.4
2.2
3
2.8
4.8
6.1
0.3
0.1
0
2
8
7.4
4
1

balance-sheet.row.total-non-current-liabilities

990.16206.4279.5261.1
296.1
264.5
242.9
157.8
155.3
142.6
42.3
29
41.9
35.9
40.2
57.5
73.9
83.2
81.3
53.1
7.4
12.7
1.3
1.4
2.7
2.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

291.367.265.344.7
36
9.4
0.1
0.3
0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

1839.38462.3468.5418
426
386.7
310.9
214.2
196.1
171.5
51.5
39.3
46.7
40.6
45.6
62.8
80.9
91.6
90.3
72.3
26.6
34.8
11.3
17.6
11.3
4.3

balance-sheet.row.preferred-stock

0313.9413.6466
26.9
26.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

14.853.93.12.6
2
1.4
1.2
1
0.9
0.9
0.6
0.4
0.2
0.2
1.1
0.9
0.7
0.5
0.5
0.5
0.5
0.4
0.3
0.3
0.3
90

balance-sheet.row.retained-earnings

-7490.38-1955.7-1709.9-1489.8
-1465.9
-1285
-1177.3
-1026.5
-905.3
-779.2
-691.3
-649.1
-619
-607.7
-584.4
-562.5
-527.3
-498.6
-461.8
-410
-335.9
-279.7
-213.8
-157.9
-84.3
-37.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-1.78-10.91.5
2.8
-1.3
-1.5
-2.2
-1.5
-2.1
-2
-27.6
-27.4
-26.1
-25
-28.6
-25.9
-22.6
0
-0.1
-0.2
0.1
-0.2
-0.7
-1.5
-0.7

balance-sheet.row.other-total-stockholders-equity

7036.141478.41231.11054.3
1230.6
1032.7
1005.2
951.8
866.9
851.1
715.7
671.9
628.6
607.1
593.6
573.2
528.6
473.7
444
441.5
442
384.5
291.4
234.2
202.3
0

balance-sheet.row.total-stockholders-equity

-441.17-160.3-61.334.4
-203.7
-225.4
-172.5
-75.8
-39.1
70.7
23
-4.5
-17.6
-26.4
-14.7
-17
-23.9
-47.1
-17.4
31.9
106.4
105.2
77.8
75.9
116.7
51.7

balance-sheet.row.total-liabilities-and-stockholders-equity

1445.83313.9413.6466
214.5
155.3
136.4
138.4
157
242.2
74.5
34.8
34.7
19.8
30.9
45.9
56.9
44.5
73
104.2
133.1
140.1
89.1
93.5
128
56

balance-sheet.row.minority-interest

47.6311.96.413.5
-7.8
-6
-2.1
0
0
0
0
0
5.6
5.6
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

-393.54-148.4-54.947.9
-211.5
-231.3
-174.5
-75.8
-39.1
70.7
23
-4.5
-12
-20.8
-14.7
-17
-23.9
-47.1
-17.4
31.9
106.4
105.2
77.8
75.9
116.7
51.7

balance-sheet.row.total-liabilities-and-total-equity

1445.83---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

46.43.714.715
2.6
0
0
0
5
35
14.5
0
0
0
0
10
10
4.2
15.9
28.5
70.9
32.3
25.6
0
3
0

balance-sheet.row.total-debt

614.37350.278.458.3
55.7
23.4
13.4
163
130.7
114.5
6
8.9
35.9
32.9
34.2
49.6
68
77.5
75.5
4.2
9.9
15.9
0.6
6.1
5
3

balance-sheet.row.net-debt

123.93274.1-100.2-233.6
-44.1
-38.4
-39.7
102.8
54.3
-57.2
-34.2
-18.5
14.4
22.2
14.4
29.6
43.5
63.1
51.3
-29
-6.1
-41.3
-32.6
-54.8
-91.2
-43.4

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Agenus Inc. opazno spremenil prosti denarni tok, ki se je spremenil v -0.025. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 133.96, kar kaže na razliko 29.058 v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini 3400000.000 v valuti poročanja. To je premik za -1.101 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 13.59, 0 in -8.93, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo 0 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane -0.61, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

-255.15-245.8-230.7-28.7
-182.9
-111.6
-162
-120.7
-127
-87.9
-42.5
-30.1
-11.3
-23.3
-21.9
-30.3
-28.7
-36.8
-51.9
-74.1
-68.8
-65.9
-55.9
-73.5
-46.7
-18.1

cash-flows.row.depreciation-and-amortization

13.5913.66.96.8
7.2
6.7
6.3
6
4.9
14.2
1.6
0.6
1.6
2.3
3.4
4.1
4.7
5.4
5.7
5.6
4.8
6.5
5.5
4.1
1.7
1

cash-flows.row.deferred-income-tax

-29.66-52.10-9.5
2.9
0.1
10.9
0
0
-5.4
0
2.7
0
23.3
-2
-2.3
-13.2
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

22.8722.918.319.6
10.4
9.9
7.6
12.4
13.2
7.4
4.7
4.1
4.3
2.6
3.2
3.1
5.6
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

10.7610.824.1-9.7
9
58.7
0.2
-6.5
10.4
6.6
-6
1.3
3.3
-2.1
0.4
-2.8
0.5
-0.4
-3.6
2
-0.4
6.7
-2.8
-3.3
1.7
-1.4

cash-flows.row.account-receivables

-23.46-23.50.1-0.4
16.2
-15.4
0.2
10.2
-1.5
-9.3
0
0.6
-0.6
0
0
-2.3
0.3
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

2.6300-6.2
3.6
0.1
0
0
17.6
0
-0.1
0
0
0
0.3
-0.1
0.3
-0.1
-0.2
-0.1
0.1
0
-0.2
-0.7
0.2
0

cash-flows.row.account-payables

21.3721.46.510.8
2.8
-0.2
5.4
1.6
0.4
2.7
0
0.2
-0.2
0
-0.2
0.3
-0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

10.2212.917.5-14
-13.6
74.2
-5.4
-18.4
-6.1
13.3
-5.9
0.5
4
-2.1
0.3
-0.7
0.1
-0.4
-3.4
2
-0.5
6.7
-2.7
-2.6
1.4
0

cash-flows.row.other-non-cash-items

28.9526.55.931.7
14.3
17.6
6
14.5
18.5
17.8
4
1.8
3.1
-19.1
2.1
4
2.2
5.1
4.9
0.2
4.1
1.5
2.4
35.8
28.3
5

cash-flows.row.net-cash-provided-by-operating-activities

-208.64000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-4.56-10-53.1-33.8
-3.5
-4.7
-3.6
-3.1
-12.5
-3.6
-2.8
-0.8
-0.1
-0.1
-0.1
-0.2
-0.2
0
-0.3
-2.7
-4
-18.5
-2.3
-1.7
-2.6
-4.9

cash-flows.row.acquisitions-net

5.213.4-2.95.7
-1
0
0
0
0
-7.2
0.5
0
0
0
0
0.1
0
0
0
0
12.6
0
0
0
0
0

cash-flows.row.purchases-of-investments

-25.44-20-24.6-15
0
0
0
-14.9
-54.9
-35
-14.5
0
0
-5
-30
-30
-29.9
-11.2
-8.4
-100.9
-133.7
-57.2
-46.1
0
0
0

cash-flows.row.sales-maturities-of-investments

30.033025-5.7
0
0
0
20
85
14.5
0
0.5
0
5
40
30
24.1
24.4
21.1
143.4
126.1
50.5
20.5
3
0
0

cash-flows.row.other-investing-activites

21.160225.7
0
0
0
0.1
0
0
0
0
0
0
0.1
2.3
2
0
3
2
3
-7.3
-0.3
1.7
1
0

cash-flows.row.net-cash-used-for-investing-activites

3.43.4-33.6-43.1
-4.4
-4.7
-3.6
2.1
17.6
-31.2
-16.8
-0.4
-0.1
0
9.9
2.2
-4
13.2
15.4
41.8
3.9
-32.5
-28.2
3
-1.6
-4.9

cash-flows.row.debt-repayment

-8.93-8.9-0.5-1.3
-3.2
-0.3
-162.1
-0.3
-0.1
-1.1
-3.3
-10.6
-0.1
0
-6.2
-0.3
-2.9
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

133.1613499.2220.6
176.4
30
44.9
65.6
2.2
109.7
56.8
26.5
10.5
8
11.6
18.6
0.3
4.8
0.5
0.3
54.6
92.6
0.6
0.2
0.6
0

cash-flows.row.common-stock-repurchased

-4.33-4.6-3.8-1.7
0
0
0
-0.5
-0.7
0
-0.5
0
-0.6
0
0
-0.1
-0.3
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

000-9.1
0
0
0
-16
-1.2
0
-0.5
0
-0.6
-0.8
-0.8
-0.8
-0.8
-0.8
-0.8
-0.8
-0.8
0
0
0
0
0

cash-flows.row.other-financing-activites

0.29-0.60.916.7
10.7
1.6
245.5
31.8
-2.6
81
0.3
9.9
0.6
0.1
0
0.1
46.6
-0.3
20.9
42.3
-5.9
15.2
50.7
-1.7
65.9
42.6

cash-flows.row.net-cash-used-provided-by-financing-activities

119.87119.995.8225.3
183.9
31.3
128.3
80.5
-2.5
189.6
52.8
25.8
9.8
7.2
4.5
17.6
42.9
3.8
20.6
41.8
47.9
107.8
51.3
-1.4
66.5
42.6

cash-flows.row.effect-of-forex-changes-on-cash

-0.63-0.6-0.1-0.2
0.4
0.8
-0.7
0.4
-0.4
-0.2
0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-101.56-102.6-113.3192.1
40.7
8.8
-7.1
-11.3
-65.3
111
-1.6
5.9
10.7
-9
-0.3
-4.4
10
-9.7
-9
17.2
-8.4
24.1
-27.7
-35.3
49.7
24.2

cash-flows.row.cash-at-end-of-period

499.4576.1181.3294.6
102.5
61.8
53.1
60.2
71.4
136.7
25.7
27.4
21.5
10.7
19.8
20.1
24.5
14.5
24.2
33.2
16
57.2
33.1
60.9
96.1
46.4

cash-flows.row.cash-at-beginning-of-period

601.01178.7294.6102.5
61.8
53.1
60.2
71.4
136.7
25.7
27.4
21.5
10.7
19.8
20.1
24.5
14.5
24.2
33.2
16
24.4
33.1
60.9
96.1
46.4
22.2

cash-flows.row.operating-cash-flow

-208.64-224.2-175.410.1
-139.1
-18.7
-131.1
-94.2
-80
-47.2
-38.2
-19.5
1
-16.2
-14.8
-24.2
-28.9
-26.7
-44.9
-66.3
-60.2
-51.2
-50.8
-36.8
-15.1
-13.5

cash-flows.row.capital-expenditure

-4.56-10-53.1-33.8
-3.5
-4.7
-3.6
-3.1
-12.5
-3.6
-2.8
-0.8
-0.1
-0.1
-0.1
-0.2
-0.2
0
-0.3
-2.7
-4
-18.5
-2.3
-1.7
-2.6
-4.9

cash-flows.row.free-cash-flow

-213.2-234.2-228.4-23.7
-142.6
-23.3
-134.7
-97.3
-92.5
-50.8
-41.1
-20.3
0.9
-16.3
-14.9
-24.4
-29.1
-26.7
-45.3
-69
-64.2
-69.7
-53.1
-38.5
-17.8
-18.4

Vrstica izkaza poslovnega izida

Prihodki Agenus Inc. so se v primerjavi s prejšnjim obdobjem spremenili za 0.595%. Bruto dobiček podjetja AGEN znaša 139.62. Odhodki iz poslovanja podjetja so 299.72 in so se v primerjavi s prejšnjim letom spremenili za 269.993%. Odhodki za amortizacijo znašajo 13.59, kar je -0.273% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 299.72, ki kaže 269.993% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja 0.108% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so -160.1, ki kažejo -0.108% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je -0.095%. Čisti prihodki v zadnjem letu so znašali -245.76.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

income-statement-row.row.total-revenue

156.31156.398295.7
88.2
150
36.8
42.9
22.6
24.8
7
3
16
2.8
3.4
3.3
2.7
5.6
0.7
0.6
0.7
4.4
3.4
4.6
0.4
0.1

income-statement-row.row.cost-of-revenue

176.1616.7197.3182.1
145
168.3
124.6
116.1
95
70.4
22.3
13.5
11.2
0
0.1
0
0
0
0
0
0
1.9
1.3
1.1
-1.3
0

income-statement-row.row.gross-profit

-19.84139.6-99.2113.6
-56.8
-18.3
-87.8
-73.2
-72.4
-45.6
-15.4
-10.5
4.7
2.8
3.2
3.3
2.7
5.6
0.7
0.6
0.7
2.5
2.1
3.5
1.8
0.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

75.24---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

78.74---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

-5.2---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-1.490-175.1
-1.9
-168.3
-2.2
-16.9
-19.5
-7.2
0.8
-5.1
-4.6
0
0
0
0
0
0
0
0
0
0
0
1.7
1

income-statement-row.row.operating-expenses

140.26299.78176.4
59.2
46
37.3
33.7
33.1
28.4
21.3
14.5
11.5
21.8
25
31
40.5
38.8
49.9
74.5
67.5
70.2
59.4
45.1
28.4
18.9

income-statement-row.row.cost-and-expenses

316.42316.4278.3258.4
204.2
214.4
161.9
149.9
128.1
98.8
43.6
28
22.7
21.8
25.1
31
40.5
38.8
49.9
74.5
67.5
72.2
60.8
46.2
27.1
18.9

income-statement-row.row.interest-income

53.74061.965.7
61.1
41.5
0
0
0
0
0
0
0
0
0
0.1
0
1.5
1.9
2.8
1.5
1.2
1.6
3.4
6.2
0

income-statement-row.row.interest-expense

99.4597.961.965.7
61.1
41.5
25.3
18.9
17.3
6.6
1.3
2.4
4.7
4.2
4.9
5.3
5.1
5
3.3
3
0.5
0.2
0.4
0.7
0.4
0

income-statement-row.row.selling-and-marketing-expenses

-5.2---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-59.46-97.3-51.2-71
-65.7
-41.4
-11.6
-13.7
-21.5
-13.9
-5.9
-5.1
-4.6
0
4.7
-2.6
14.2
0
-1.2
0
-2.9
0.9
0.3
-34.6
-25.8
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-1.490-175.1
-1.9
-168.3
-2.2
-16.9
-19.5
-7.2
0.8
-5.1
-4.6
0
0
0
0
0
0
0
0
0
0
0
1.7
1

income-statement-row.row.total-operating-expenses

-59.46-97.3-51.2-71
-65.7
-41.4
-11.6
-13.7
-21.5
-13.9
-5.9
-5.1
-4.6
0
4.7
-2.6
14.2
0
-1.2
0
-2.9
0.9
0.3
-34.6
-25.8
0

income-statement-row.row.interest-expense

99.4597.961.965.7
61.1
41.5
25.3
18.9
17.3
6.6
1.3
2.4
4.7
4.2
4.9
5.3
5.1
5
3.3
3
0.5
0.2
0.4
0.7
0.4
0

income-statement-row.row.depreciation-and-amortization

13.2213.618.76.8
6.5
12.5
6.3
6
4.9
14.2
1.6
0.6
1.6
2.3
3.4
4.1
4.7
5.4
5.7
5.6
4.8
6.5
5.5
4.1
1.7
1

income-statement-row.row.ebitda-caps

-145.15---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-159.71-160.1-179.442.3
-117.2
-70.1
-123.8
-103.8
-107.5
-80.7
-43.3
-25
-6.7
-19.1
-21.8
-27.7
-37.8
-33.3
-50.6
-73.9
-69.7
-67.7
-57.4
-41.6
-26.7
-18.8

income-statement-row.row.income-before-tax

-257.44-257.4-230.7-28.7
-182.9
-111.6
-162
-120.7
-127
-87.9
-42.5
-30.1
-11.3
-24.1
-22.7
-31.6
-29.5
-52.7
-52.7
-74.9
12.6
-66.9
-57.1
-76.2
-52.5
0

income-statement-row.row.income-tax-expense

31.94-11.740.966
57.2
37.6
-12.9
-9.2
-3
-5.4
5.1
-0.6
-1.6
4.2
0.2
-1.5
-9.1
3.5
2.6
0.2
69.5
-1.8
-1.5
31.9
20
-0.7

income-statement-row.row.net-income

-249.77-245.8-271.5-94.7
-240.1
-149.1
-159.7
-120.7
-127
-87.9
-42.5
-30.1
-11.3
-23.3
-21.9
-30.3
-28.7
-36.8
-51.9
-74.1
-56.2
-65.9
-55.9
-73.5
-46.7
-18.1
Podobne delnice
Morda vas zanima tudi:
SRNE
Sorrento Therapeutics, Inc..
0.015 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
8.97 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.03 USD
NASDAQ
GUBRA.CO
Gubra A/S.
300 DKK
CPH
T5O.DE
CytoTools AG.
0.468 EUR
XETRA
HBC.OL
Hofseth BioCare ASA.
2.1 NOK
OSL
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42.35 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ

Pogosto zastavljeno vprašanje

Kaj je Agenus Inc. (AGEN) skupna sredstva?

Agenus Inc. (AGEN) skupna sredstva so 313913000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 108115000.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je -0.127.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.541.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -1.598.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -1.022.

Kaj je Agenus Inc. (AGEN) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -245761000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 350246000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 299720000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 76110000.000.